• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Monday, May 19, 2025
  • Login
  • Register
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Business

Moderna Stock soars up after they booster dose effective against Omicron

by Ayush Bansal
December 20, 2021
in Business, Markets, News
Reading Time: 3 mins read
0
Moderna Stock soars up after they booster dose effective against Omicron
TwitterWhatsappLinkedin

Moderna Inc. said the third dose of its Covid-19 vaccine increased immune responses against the Omicron coronavirus variant compared with two doses in lab tests. That signaling the shot could still offer protection despite the variant’s mutations.

You might also like

Antonio Filosa Emerges as Leading Candidate for Stellantis CEO Role Amid Strategic Crossroads

VerSe Innovation to Lay Off 350 Employees as Dailyhunt and Josh Shift Focus to AI and Restructuring

Indian Defence Forces Granted Emergency Procurement Powers Amid Operation Sindoor

The findings, reported by Moderna on Monday, were the latest positive—though preliminary—results from lab tests suggesting boosters can protect against the worrisome new strain.

Moderna
Moderna
Image: CNBC

The Cambridge, Mass., company said the authorized dosage of its booster shot increased levels of immune-system agents known as neutralizing antibodies. It is against Omicron about 37 times more than pre-boost levels.

The data, which has not yet been peer-reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the Omicron variant. It is similar to data discussed last by top U.S. infectious disease expert Anthony Fauci.

Burton said it would be up to governments and regulators to gauge. Whether they want the enhanced level of protection that a 100 microgram dose might confer.

The company said that the 100 microgram dose was generally safe and well-tolerated, although there was a trend toward slightly more frequent adverse reactions.

The Omicron variant is spreading fast across the world. The World Health Organization had said on December 17 that number of cases of the variant is doubling in 1.5 to 3 days in areas with community transmission. The new strain has been detected in 89 countries as of December 16, according to the global health body.

In its statement, Moderna said it was assessing the booster shots in a study comprising approximately 300 to 600 participants. The results were based on samples of 20 participants who each received the booster shots of 50 and 100 micrograms.

The company was also testing the effectiveness of Omicron-specific vaccine candidates. The statement said that the vaccine candidates showed similar efficacy.

It added that the 100 microgram booster dose of its authorized vaccine was safe and well-tolerated.

What’s Next

The company said it will also continue to develop an omicron-specific booster candidate. Which should enter clinical trials in early 2022.

The decision to focus on its current Covid-19 booster, rather than the variant-specific vaccine. It was because of both the speed of omicron’s spread and its confidence in its current offering, the company said.

“Moving forward, given the strength of the mRNA-1273 and the speed at which the Omicron variant is spreading, Moderna’s first line of defense against Omicron will be a booster dose of mRNA-1273,” the company said in its statement.

Pfizer and BioNTech Role:

Both the Moderna and the Pfizer/BioNTech vaccines have been linked to rare cases of heart inflammation, particularly in young men. Several studies have suggested that Moderna’s vaccine is likely to cause the heart inflammation at a higher rate

Pfizer and BioNTech agreed in May to supply 900 million doses to the European Commission (EC) in 2022 and 2023. With option to request up to an additional 900 million doses.

The doses announced on Monday are in addition to the 450 million already expected to be delivered in 2022, they said.

The order would cover potential vaccines adapted to the Omicron variant of the coronavirus, if such a vaccine is needed and authorized, at no additional costs, said the companies.

Tags: CoronavirusMarketModernaModerna VaccineNewsomicron
Tweet54SendShare15
Previous Post

Kunal Bahl shares the story of how Snapdeal got its first angel investor

Next Post

Ferrari’s three top managers leave as new leadership takes place

Ayush Bansal

Recommended For You

Antonio Filosa Emerges as Leading Candidate for Stellantis CEO Role Amid Strategic Crossroads

by Samir Gautam
May 18, 2025
0
Antonio Filosa Emerges as Leading Candidate for Stellantis CEO Role Amid Strategic Crossroads

Antonio Filosa, the executive currently leading Stellantis’ U.S. operations, has emerged as the top contender to succeed outgoing CEO Carlos Tavares, according to reports from Bloomberg. As Stellantis...

Read more

VerSe Innovation to Lay Off 350 Employees as Dailyhunt and Josh Shift Focus to AI and Restructuring

by Rounak Majumdar
May 18, 2025
0
VerSe Innovation to Lay Off 350 Employees as Dailyhunt and Josh Shift Focus to AI and Restructuring

The parent firm of well-known content sites Dailyhunt and Josh, VerSe Innovation, has announced a major layoff, laying off about 350 employees this month. Since the company's last...

Read more

Indian Defence Forces Granted Emergency Procurement Powers Amid Operation Sindoor

by Rounak Majumdar
May 18, 2025
0
Indian Defence Forces Granted Emergency Procurement Powers Amid Operation Sindoor

In May 2025, India's national security environment changed drastically after the disastrous Pahalgam terror strike in Jammu and Kashmir, which left 26 people dead. The Indian government responded...

Read more
Next Post
Ferrari’s three top managers leave as new leadership takes place

Ferrari's three top managers leave as new leadership takes place

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook flipkart funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?